CUKUROVA MEDICAL JOURNAL, cilt.45, sa.3, ss.933-939, 2020 (ESCI)
Purpose: The aim of this study to discuss frequency and clinical significance of JAK2-V617F, Calreticulin (CALR type 1 and type-2) and MPL-W515K/L mutations in patients at initial diagnosis of bcr-abl negative chronic myeloproliferative diseases (CMPD).